Amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides targeting α-synuclein as a novel therapy for Parkinson’s disease

Parkinson’s disease (PD) is a neurodegenerative disease caused by the loss of dopaminergic neurons in the substantia nigra. A characteristic pathological feature of PD is cytoplasmic accumulation of α-synuclein (SNCA) protein. Multiplication of the SNCA gene in familial PD and pathological accumulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Uehara, Takuya, Choong, Chi-Jing, Nakamori, Masayuki, Hayakawa, Hideki, Nishiyama, Kumiko, Kasahara, Yuuya, Baba, Kousuke, Nagata, Tetsuya, Yokota, Takanori, Tsuda, Hiroshi, Obika, Satoshi, Mochizuki, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527855/
https://www.ncbi.nlm.nih.gov/pubmed/31110191
http://dx.doi.org/10.1038/s41598-019-43772-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527855/
https://www.ncbi.nlm.nih.gov/pubmed/31110191
http://dx.doi.org/10.1038/s41598-019-43772-9

Ejemplares similares